ZYRTEC

This brand name is authorized in Austria, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, France, Hong Kong, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, South Africa

Active ingredients

The drug ZYRTEC contains one active pharmaceutical ingredient (API):

1 Cetirizine
UNII 64O047KTOA - CETIRIZINE HYDROCHLORIDE

Cetirizine, a human metabolite of hydroxyzine, is a potent and selective antagonist of peripheral H1-receptors. In vitro receptor binding studies have shown no measurable affinity for other than Η1-receptors.

Read about Cetirizine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ZYRTEC Film-coated tablet / Oral drops / Oral solution Health Sciences Authority (SG) MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R06AE07 Cetirizine R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AE Piperazine derivatives
Discover more medicines within R06AE07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 510609601112312, 510609603131314
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 00243748, 00257940, 01433215, 01433221, 01433238, 01467852, 03738203, 04394326, 04394332, 04811126, 04811149, 04811155, 04967029, 04967041, 07736394
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 30024-11-11, 30047-11-11, 30058-12-11
Country: EE Ravimiamet Identifier(s): 1022858, 1022869, 1026526, 1077825, 1077836, 1077847, 1525014, 1525025, 1525047, 1525058, 1525115, 1525126, 1525171, 1525182, 1525193, 1525205, 1525216, 1525227, 1525238, 1525249, 1525250, 1525261, 1525272, 1525283, 1728637, 1731563, 1731574, 1731585, 1826580, 1828537, 1829897, 1829909
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 58481, 60279, 60280, R-1846, R-1846IP, R1846
Country: FR Base de données publique des médicaments Identifier(s): 64949486, 65016707
Country: HK Department of Health Drug Office Identifier(s): 33733, 40728
Country: JP 医薬品医療機器総合機構 Identifier(s): 4490020F1020, 4490020F2027, 4490020R1027
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1003218, 1003219, 1010903, 1010904, 1065605, 1066078, 1069324, 1082128, 1084154, 1085498, 1085687, 1086334, 1088373, 1091412, 1091413
Country: MT Medicines Authority Identifier(s): MA030/00901, MA030/00902, PI908/01901A
Country: NL Z-Index G-Standaard, PRK Identifier(s): 26298, 38601
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 6329, 6330
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100001901, 100074834, 100074857, 100131970, 100412515, 100454164
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W59369001, W59369002, W59369003
Country: SG Health Sciences Authority Identifier(s): 03022P, 08945P, 10796P, 14890P, 15437P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 9073241
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699624090041, 8699624570048, 8699624590015
Country: ZA Health Products Regulatory Authority Identifier(s): 28/5.7.1/0477, W/5.7.1/148

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.